Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Case Study Organization & Performance Procurement Excellence as Competitive Advantage: Lowering Costs to Elevate Products May 6, 2025
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
Published Articles Life Sciences & Pharma A Strategic Framework for Evaluating AI in Drug Discovery December 6, 2024
Article Healthcare Services Healthcare Crossroads? The 2024 Election and What’s Really at Stake October 29, 2024
Published Articles Business Services What do leaders get wrong when making high-risk decisions? October 10, 2024
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024